Skip to content
Screener

AbCellera Biologics Inc. ABCL Non-cash investing activities

Non-cash investing activities at other companies

REX American Resources logo
REX American ResourcesREX
$7.81M+187%
Delek Logistics Partners logo
Delek Logistics PartnersDKL
$0-100%
Delek Logistics Partners logo
Delek Logistics PartnersDKL
$0-100%
First Merchants Corporation logo
First Merchants CorporationFRME
$0-100%
Silvercrest Asset Management Group logo
Silvercrest Asset Management GroupSAMG
$17K+143%
Kulicke & Soffa Industries logo
Kulicke & Soffa IndustriesKLIC
-$46K

Other financials

Income statement

See full
Revenue$4.1M-76.3%
Operating income-$62.8M-26.6%
Net income-$55.4M-59.6%
EPS (diluted)-$0.18-50.0%

Balance sheet

See full
Cash & equivalents$145.1M+23.5%
Total debt$135.6M-4.5%
Total equity$896.0M-11.0%
Total assets$1.3B-6.7%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$2.1M-84.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$1.81B+47.0%
Enterprise value$1.8B+43.4%
P/S27.3×-10.1×

Profitability

See full
Operating margin-340.3%-127pp
Net margin-248.8%-83.6pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-17.3%+2.1pp
Debt / equity0.2×0.0×
Current ratio12.8×+1.7×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept abcl:GovernmentAssistanceNonCashInvestingActivities.

The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001703057-26-000046

5For the three months ended June 30, 2025 and 2026, the Company recognized non-cash investing activities for uncollected government grants of $1.6 million and $0.3 million, respectively, and non-cash financing activities of $10.7 million and $5.1 million, respectively. For the six months ended June 30, 2025 and 2026, non-cash investing activities were $2.4 million and $0.5 million, respectively, and non-cash financing activities were $19.0 million and $10.0 million, respectively.

Item 1. Financial Statements (Unaudited)

FAQ

What is AbCellera Biologics Inc.'s non-cash investing activities?
AbCellera Biologics Inc. (ABCL) reported non-cash investing activities of $300K in Q2 2026.
What does non-cash investing activities mean?
Non-cash investing activities as reported by AbCellera Biologics Inc. Common Shares.

Ask your AI about AbCellera Biologics Inc.'s non-cash investing activities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude